 |
|||||||||
   |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Nasopharyngeal Carcinoma
H9935; Administration of EBV-Specific T-Lymphocytes to Patients with EBV-Positive Nasopharyngeal Carcinoma: This study uses autologous EBV specific T-Lymphocytes to treat nasopharyngeal carcinoma.
H14214; Administration of EBV-specific Cytotoxic T Lymphocytes Following CD45 Antibody to Patients with EBV Positive Nasopharyngeal Carcinoma: This study uses a monoclonal antibody and autologous EBV specific T-Lymphocytes to treat nasopharyngeal carcinoma.
©2002,
Cell And Gene Therapy, Baylor College
of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy
Email:cagt@bcm.edu
(Modified: September 21st, 2007 - jb)
